Posts Tagged ‘AIDS’

Scientists Allege By: Dr. Cyril Broderick, Professor of Plant Pathology Dear World Citizens: I have read a number of articles from your Internet outreach as well as articles from other sources about the casualties in Liberia and other West African countries about the human devastation caused by the Ebola virus. About a week ago, I read an article published in the Internet news summary publication of the Friends of Liberia that said that there was an agreement that the initiation of the Ebola outbreak in West Africa was due to the contact of a two-year old child with bats that had flown in from the Congo. That report made me disconcerted with the reporting about Ebola, and it stimulated a response to the “Friends of Liberia,” saying that African people are not ignorant and gullible, as is being implicated. A response from Dr. Verlon Stone said that the article was not theirs, and that “Friends of Liberia” was simply providing a service. He then asked if he could publish my letter in their Internet forum. I gave my permission, but I have not seen it published. Because of the widespread loss of life, fear, physiological trauma, and despair among Liberians and other West African citizens, it is incumbent that I make a contribution to the resolution of this devastating situation, which may continue to recur, if it is not properly and adequately confronted. I will address the situation in five (5) points: 1. EBOLA IS A GENETICALLY MODIFIED ORGANISM (GMO) Horowitz (1998) was deliberate and unambiguous when he explained the threat of new diseases in his text, Emerging Viruses: AIDS and Ebola – Nature, Accident or Intentional. In his interview with Dr. Robert Strecker in Chapter 7, the discussion, in the early 1970s, made it obvious that the war was between countries that hosted the KGB and the CIA, and the ‘manufacture’ of ‘AIDS-Like Viruses’ was clearly directed at the other. In passing during the Interview, mention was made of Fort Detrick, “the Ebola Building,” and ‘a lot of problems with strange illnesses’ in “Frederick [Maryland].” By Chapter 12 in his text, he had confirmed the existence of an American Military-Medical-Industry that conducts biological weapons tests under the guise of administering vaccinations to control diseases and improve the health of “black Africans overseas.” The book is an excellent text, and all leaders plus anyone who has interest in science, health, people, and intrigue should study it. I am amazed that African leaders are making no acknowledgements or reference to these documents. 2. EBOLA HAS A TERRIBLE HISTORY, AND TESTING HAS BEEN SECRETLY TAKING PLACE IN AFRICA I am now reading The Hot Zone, a novel, by Richard Preston (copyrighted 1989 and 1994); it is heart-rending. The prolific and prominent writer, Steven King, is quoted as saying that the book is “One of the most horrifying things I have ever read. What a remarkable piece of work.” As a New York Times bestseller, The Hot Zone is presented as “A terrifying true story.” Terrifying, yes, because the pathological description of what was found in animals killed by the Ebola virus is what the virus has been doing to citizens of Guinea, Sierra Leone and Liberia in its most recent outbreak: Ebola virus destroys peoples’ internal organs and the body deteriorates rapidly after death. It softens and the tissues turn into jelly, even if it is refrigerated to keep it cold. Spontaneous liquefaction is what happens to the body of people killed by the Ebola virus! The author noted in Point 1, Dr. Horowitz, chides The Hot Zone for writing to be politically correct; I understand because his book makes every effort to be very factual. The 1976 Ebola incident in Zaire, during President Mobutu Sese Seko, was the introduction of the GMO Ebola to Africa. 3. SITES AROUND AFRICA, AND IN WEST AFRICA, HAVE OVER THE YEARS BEEN SET UP FOR TESTING EMERGING DISEASES, ESPECIALLY EBOLA The World Health Organization (WHO) and several other UN Agencies have been implicated in selecting and enticing African countries to participate in the testing events, promoting vaccinations, but pursuing various testing regiments. The August 2, 2014 article, West Africa: What are US Biological Warfare Researchers Doing in the Ebola Zone? by Jon Rappoport of Global Research pinpoints the problem that is facing African governments. Obvious in this and other reports are, among others: (a) The US Army Medical Research Institute of Infectious Diseases (USAMRIID), a well-known centre for bio-war research, located at Fort Detrick, Maryland; (b) Tulane University, in New Orleans, USA, winner of research grants, including a grant of more than $7 million the National Institute of Health (NIH) to fund research with the Lassa viral hemorrhagic fever; (c) the US Center for Disease Control (CDC); (d) Doctors Without Borders (also known by its French name, Medicins Sans Frontiers); (e) Tekmira, a Canadian pharmaceutical company; (f) The UK’s GlaxoSmithKline; and (g) the Kenema Government Hospital in Kenema, Sierra Leone. Reports narrate stories of the US Department of Defense (DoD) funding Ebola trials on humans, trials which started just weeks before the Ebola outbreak in Guinea and Sierra Leone. The reports continue and state that the DoD gave a contract worth $140 million dollars to Tekmira, a Canadian pharmaceutical company, to conduct Ebola research. This research work involved injecting and infusing healthy humans with the deadly Ebola virus. Hence, the DoD is listed as a collaborator in a “First in Human” Ebola clinical trial (NCT02041715, which started in January 2014 shortly before an Ebola epidemic was declared in West Africa in March. Disturbingly, many reports also conclude that the US government has a viral fever bioterrorism research laboratory in Kenema, a town at the epicentre of the Ebola outbreak in West Africa. The only relevant positive and ethical olive-branch seen in all of my reading is that Theguardian.com reported, “The US government funding of Ebola trials on healthy humans comes amid warnings by top scientists in Harvard and Yale that such virus experiments risk triggering a worldwide pandemic.” That threat still persists. 4. THE NEED FOR LEGAL ACTION TO OBTAIN REDRESS FOR DAMAGES INCURRED DUE TO THE PERPETUATION OF INJUSTICE IN THE DEATH, INJURY AND TRAUMA IMPOSED ON LIBERIANS AND OTHER AFRICANS BY THE EBOLA AND OTHER DISEASE AGENTS. The U. S., Canada, France, and the U. K. are all implicated in the detestable and devilish deeds that these Ebola tests are. There is the need to pursue criminal and civil redress for damages, and African countries and people should secure legal representation to seek damages from these countries, some corporations, and the United Nations. Evidence seems abundant against Tulane University, and suits should start there. Yoichi Shimatsu’s article, The Ebola Breakout Coincided with UN Vaccine Campaigns, as published on August 18, 2014, in the Liberty Beacon. 5. AFRICAN LEADERS AND AFRICAN COUNTRIES NEED TO TAKE THE LEAD IN DEFENDING BABIES, CHILDREN, AFRICAN WOMEN, AFRICAN MEN, AND THE ELDERLY. THESE CITIZENS DO NOT DESERVE TO BE USED AS GUINEA PIGS! Africa must not relegate the Continent to become the locality for disposal and the deposition of hazardous chemicals, dangerous drugs, and chemical or biological agents of emerging diseases. There is urgent need for affirmative action in protecting the less affluent of poorer countries, especially African citizens, whose countries are not as scientifically and industrially endowed as the United States and most Western countries, sources of most viral or bacterial GMOs that are strategically designed as biological weapons. It is most disturbing that the U. S. Government has been operating a viral hemorrhagic fever bioterrorism research laboratory in Sierra Leone. Are there others? Wherever they exist, it is time to terminate them. If any other sites exist, it is advisable to follow the delayed but essential step: Sierra Leone closed the US bioweapons lab and stopped Tulane University for further testing. The world must be alarmed. All Africans, Americans, Europeans, Middle Easterners, Asians, and people from every conclave on Earth should be astonished. African people, notably citizens more particularly of Liberia, Guinea and Sierra Leone are victimized and are dying every day. Listen to the people who distrust the hospitals, who cannot shake hands, hug their relatives and friends. Innocent people are dying, and they need our help. The countries are poor and cannot afford the whole lot of personal protection equipment (PPE) that the situation requires. The threat is real, and it is larger than a few African countries. The challenge is global, and we request assistance from everywhere, including China, Japan, Australia, India, Germany, Italy, and even kind-hearted people in the U.S., France, the U.K., Russia, Korea, Saudi Arabia, and anywhere else whose desire is to help. The situation is bleaker than we on the outside can imagine, and we must provide assistance however we can. To ensure a future that has less of this kind of drama, it is important that we now demand that our leaders and governments be honest, transparent, fair, and productively engaged. They must answer to the people. Please stand up to stop Ebola testing and the spread of this dastardly disease. Thank you very much. Sincerely, Dr. Cyril E. Broderick, Sr. About the Author: Dr. Broderick is a former professor of Plant Pathology at the University of Liberia’s College of Agriculture and Forestry. He is also the former Observer Farmer in the 1980s. It was from this column in our newspaper, the Daily Observer, that Firestone spotted him and offered him the position of Director of Research in the late 1980s. In addition, he is a scientist, who has taught for many years at the Agricultural College of the University of Delaware. Source: http://www.liberianobserver.com/security/ebola-aids-manufactured-western-pharmaceuticals-us-dod

http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4647773 Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Abstract A cell system is disclosed for the reproducible detection and isolation of human T-lymphotropic retroviruses (HTLV-family) with cytopathic effects (HTLV-III) from patients with the acquired immune deficiency syndrome (AIDS), pre-AIDS and in healthy carriers. One neoplastic aneuploid T-cell line derived from an adult with lymphoid leukemia, and termed HT, was susceptible to infection with the new variants of HTLV, which are transformed and providing T-cell populations which are highly susceptible and permissive from HTLV-III, and convenience for large scale production, isolation and biological detection of the virus. Inventors: Gallo; Robert C. (Bethesda, MD), Popovic; Mikulas (Bethesda, MD) Assignee: The United States of America as represented by the Department of Health (Washington, DC) [*] Notice: The portion of the term of this patent subsequent to May 28, 2002 has been disclaimed. Appl. No.: 06/602,946 Filed: April 23, 1984 Current U.S. Class: 435/239 ; 424/208.1; 435/235.1; 435/372.3; 435/948 Current International Class: C12N 5/06 (20060101); C12N 7/00 (20060101); C12N 007/02 (); C12N 007/00 (); C12N 005/00 (); C12R 001/91 () Field of Search: 435/235,239,240,948,5,29 424/89 128/1T References Cited [Referenced By] U.S. Patent Documents 4464465 August 1984 Lostrom et al. 4520113 May 1985 Gallo et al. Other References Popovic et al, Science, 224(4648):497-500, May 4, 1984. . Gallo et al, “Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)”, Science, 220, pp. 865-867 (5-1983). . Barre-Sinoussi et al, “Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for AIDS”, Science, 220, pp. 868-871 (5-1983). . Marx, “Strong New Candidate for AIDS Agent”, Science, 224, pp. 475-477 (5-1984).. Primary Examiner: Warren; Charles F. Assistant Examiner: Tarcza; John Edward Attorney, Agent or Firm: Roberts, Jr.; John S. Claims We claim: 1. A method for continuous production of HTLV-III virus which comprises infecting in cell culture highly susceptible, permissive cells consisting of a neoplastic aneuploid HT-cell line with said virus, said cells preserve the capacity for permanent growth after the infection with said virus, growing said cells under conditions suitable for cell growth and recovering said virus produced by said cells. 2. The method of claim 1, wherein said virus consists of cytopathic variants of HTLV. 3. The method of claim 1 wherein said infecting comprises cocultivating said virus with said cells to produce a cell line and recovering said cell line. 4. The method of claim 1 wherein said infecting comprises cell-free infection of said cells with said virus. 5. The method of claim 1 wherein said cells are neoplastic aneuploid T-cells derived from an adult with lymphoid leukemia. 6. A process for the continuous production of HTLV-III virus which comprises cocultivating said virus with a target HT-cell to produce an infected cell line, growing said cell line and recovering said virus from supernatants produced by said cell line. 7. The process of claim 6 wherein said target T-cell is a neoplastic aneuploid T-cell susceptible to infection with HTLV-III. 8. A process for the continual production of HTLV-III by infecting T-cells in cultures which comprises cocultivating HTLV-III virus with an HT-clone to produce an infected cell line, said clone being an aneuploid T-cell line derived from lymphoid leukemia, growing said cell line and recovering said virus from supernatants produced by said cell line. 9. The process in claim 8 wherein said clone is a mature T-cell phenotype of OKT3.sup.+ (62%), OKT4.sup.+ (39%) and OKT8.sup.-. 10. A method of producing a cell line containing an antigen of HTLV-III which comprises infecting an HT-cell line derived from lymphoid leukemia and susceptible to infection with HTLV-III, said cell line is capable of continuous large-scale production of HTLV-III, and growing the infected cell line under conditions suitable for growth. 11. The method of claim 10 wherein said cell line is a neoplastic aneuploid T-cell line. 12. The method of claim 10 wherein said HTLV-III are variants of human T-lymphotropic retrovirus, exhibit cytopathic effects and are non-transforming. 13. A cell line containing HTLV-III designated H9/HTLV-III.sub.B, ATCC Accession CRL 8543. 14. A process for producing a cell line H9/HTLV-III.sub.B which comprises infecting a target T-cell with HTLV-III virus to produce a cell line and recovering same, said infecting process overcomes the normal cytopathic effect of HTLV-III and preserves the immortal growth capacity of the target cell. 15. An HT cell line permanently infected with HTLV-III virus, wherein said cell line continually produces said virus. Description The present invention describes a cell system for the reproducible detection and isolation of human T-lymphotropic retroviruses (HTLV-family) with cytopathic or cell killing effects (HTLV-III) from patients with the acquired immune deficiency syndrome (AIDS), pre-AIDS and in healthy carriers. One neoplastic aneuploid T-cell line derived from an adult with lymphoid leukemia, and termed HT, was susceptible to infection with the new variants of HTLV, providing T-cell populations which are highly susceptible and permissive for HTLV-III, and convenience for large scale production, isolation, and biological detection of the virus. BACKGROUND OF THE INVENTION The disclosure of this invention is contained in the following journal articles: Gallo et al., “Detection, Isolation, and Continuous Production of Cytopathic Human T-Lymphotropic Retroviruses (HTLV-III) from Patients with AIDS and pre-AIDS,” Science, in press; and Gallo et al., “Human T-Lymphotropic Retrovirus, HTLV-III, Isolated from AIDS Patients and Donors at Risk for AIDS,” in press. Epidemiologic data strongly suggest that acquired immune deficiency syndrome (AIDS) is caused by an infectious agent which is apparently horizontally transmitted by intimate contact or blood products. Though the disease is manifested by opportunistic infections, predominantly Pneumocystis carcinii pneumonia and Kaposi’s sarcoma, the underlying disorder affects the patient’s cell-mediated immunity with absolute lymphopenia and reduced helper T-lymphocyte (OKT4.sup.+) subpopulation(s). Moreover, before a complete clinical manifestation of the disease occurs, its prodrome, pre-AIDS, is frequently characterized by unexplained chronical lymphadenopathy and/or leukopenia involving a helper T cell subset. This leads to the severe immune deficiency of the patient, suggesting that a specific subset of T-cells is the primary target for an infectious agent. Although patients with AIDS or pre-AIDS are often chronically infected with cytomegalovirus or hepatitis B virus, for various reasons these appear to be opportunistic or coincidental infections apparently not linked to the immunological response deficiency. It is believed that the cause of AIDS may be a virus from the family of human T-cell lymphotropic retroviruses (HTLV) which, prior to the present invention, comprised two major well characterized subgroups of human retroviruses, called human T-cell leukemia/lymphoma viruses, HTLV-I and HTLV-II. The most common isolate, HTLV-I, is mainly obtained from patients with mature T-cell malignancies. Seroepidemiological studies, in vitro biological effects, and nucleic acid hybridization data indicate that HTLV-I is etiologically associated with these malignancies, affecting adults primarily in the south of Japan, the Caribbean and Africa. HTLV of subgroup II (HTLV-II) was first isolated from a patient with a T-cell variant of hairy cell leukemia. To date, this is the only reported isolate of HTLV-II from a patient with a neoplastic disease. Virus isolation and seroepidemiological data show that HTLV of both subgroups can sometimes be found in patients with AIDS. Evidence suggests that the retrovirus(es) of the HTLV family is an etiological agent of AIDS based on the following: (1) there is precedence for an animal retrovirus cause of immune deficiency (feline leukemia virus in cats); (2) retroviruses of the HTLV family are T-cell tropic; (3) they preferentially infect “helper” T-cells (OKT4.sup.+); (4) they have cytopathic effects on various human and mammalian cells as demonstrated by their induction of cell syncytia formation; (5) they can alter some T-cell functions; (6) in some cases infection may result in selective T-cell killing; and (7) they are transmitted by intimate contact or through blood products. The presence of antibodies directed to cell membrane antigens of HTLV infected cells has been shown in sera of more than 40% of patients with AIDS [Essex et al., Science, 220:859 (1983)]. This antigen has since been defined as part of the envelope of HTLV [Schupbach, et al., Science, in press; and Lee, et al., Proc. Nat. Acad. Sci. U.S.A., in press]. The original detection and isolation of the various HTLV isolates were made possible by two earlier developments: the discovery of T-cell growth factor (TCGF), also called Interleukin 2 (Il-2), which enabled the routine selective growth of different subsets of normal and neoplastic mature T-cells [Ruscetti, et al., J. Immunol., 119:131 (1977); and Poiesz, et al., Proc. Nat. Acad. Sci. U.S.A, 77:6134 (1980)] and the development of sensitive assays for detection of retroviruses based on reverse transcriptase assays. The methods of HTLV isolation and transmission involved a cocultivation procedure using permissive T-cells for the virus. The use of normal human T-cells in cocultivation experiments preferentially yielded HTLV of both subgroups with immortalizing (transforming) capability for some of the target T-cells. However, HTLV variants (now termed HTLV-III), lack immortalizing properties for normal T-cells and mainly exhibit cytopathic effects on the T-cells and is now believed to be the cause of AIDS. In fact, such variants were frequently but only transiently detected using these normal T-cells as targets in cocultivation or cell-free transmission experiments. The cytopathic effect was overcome by finding a highly susceptible, permissive cell for cytopathic variants of HTLV, thus preserving the capacity for permanent growth after infection with the virus. The present invention discloses the identification and characterization of this new immortalized T-cell population and its use in the isolation and continuous high- level production of such viruses from patients with AIDS and pre-AIDS. Early experiments identified one neoplastic aneuploid T-cell line, termed HT, derived from an adult with lymphoid leukemia, that was susceptible to infection with the new cytopathic virus isolates. This cell line is a sensitive target for transmission of these virus isolates (HTLV-III) and it allows continuous large-scale virus production and development of specific immunologic reagents and nucleic acid probes useful for comparison of these new isolates among themselves and with HTLV-I and HTLV-II. In addition to their differences in biological effects that distinguish them from HTLV-I and HTLV-II, HTLV-III also differs from these known HTLV subgroups in several immunological assays and in morphology. However, these new retroviruses are T4 lymphotropic and exhibit many properties similar to HTLV-I and II, including similar properties of the reverse transcriptase, cross reactivity of structural proteins as determined by heterologous competition radioimmune assays with patients’ sera and with animal hyperimmune sera, and induction of syncytia. These new retrovirus isolates are collectively designated HTLV-III, together with detectable differences in some of their proteins and genetic information, HTLV-III’s ability to kill T-cells clearly separates these variants from other members of the HTLV family. Read the full patent via the US patent website

Makes me ask the question as to why we are told there “is no cure” and we are “working on a cure” when clearly this Patent shows that a cure exists and is sitting around doing nothing whilst Pharmaceutical companies take all your $$$ to pay for Aids Antiretroviral Medications.

Method of curing AIDS with tetrasilver tetroxide molecular crystal devices- As per the US Patent Office. Patent #5676977

“The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans. A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of “firing” electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function.”

READ THE PATENT HERE

Let’s Talk about it!

AIDS is a major killer all around the world. Let’s all do our bit

Civilians attacked, bombed, and cut off from aid in Pakistan, Somalia, Yemen, Sri Lanka, Afghanistan, and the Democratic Republic of Congo (DRC), along with stagnant funding for treating HIV/AIDS and ongoing neglect of other diseases, were among the worst emergencies in 2009.

Continuing crises in north and south Sudan, along with the failure of the international community to finally combat childhood malnutrition were also included on this year’s list. The list is drawn from MSF’s operational activities in close to 70 countries, where the organization’s medical teams witnessed some of the worst humanitarian conditions.

via MSF’s Top Ten Humanitarian Crises of 2009.

At Save The Aids Orphans Uganda, The number of kids has lately moved up from 69 to 80 due to the increasing need in the community where local leaders have continued to plead with us to take in the most desperate kids in the community.

While my mind reasons that taking in more is impractical, my heart bleeds upon looking these teary kids in the faces and turning them away. I understand that STAO can’t help all the needy kids in the communities but we felt like taking in just 11 more would be bearable.

The challenge however has been the state of the accommodation premises. We have rooms at present, which would well take care of 80 kids with each room taking in 7 to 8 kids and 1 caregiver. However, because we lack such supplies as beds, mattresses, blankets, bed sheets, mosquito nets and some refurbishment of the rooms i.e. plastering and painting. If we got these in place, our children would have some dignity in the rooms but due to the need, the 80 children are sharing 7 rooms instead of 11 rooms. This gives each room an average of like 11 to 12 kids per room. Imagine the congestion, some of them wet their beds and so every morning gives us work to clean and put their stuff outside to have the sun kill germs. I would pray that the Lord comes through because this state makes it hard for us to control flues skin infections and other contagious conditions.

writing to ask someone to give is one of the hardest things on any relationship or so my pride tells me. However, when more than 80 children look to you for their education and other living necessities, there is not much left to do than to ask whoever will to come alongside in the cause. tomorrow is schools’ opening day, we need over $2000 in tuition, i owe the medical clinic $700, the food supplier $1050, electricity $230, water $80, nutritional supplements $210 etc etc. all this is just in debts not mentioning what is needed to run the work. All the suppliers are looking to what we owe so as to send their own kids to school. This has put us in a desperate situation which makes me frantic hence asking for givers to consider STAO. please consider to help.
Write to us at Aidsorphanseducation@gmail.com
pastor Nelson Lufafa
www.stao-uganda.org
www.stao.no

A Bulletin Received by myself from Save the Aids Orphans thorugh Myspace Australia – http://www.myspace.com/Lufafa

STOP THE PRESS!! WHATS THAT I READ???

A top LRA Commander has been captured by the UPDF!! YAY we are seeing action! Four other LRA junior commanders have been killed and 98 abductees rescued. Its good to see that things are being done, these scum are being pursued and those abducted are being rescued.

This war has been going on FAR TOO LONG and it is now, while action is happening that we must stand strong and UNITE our voices. Spread the word, let the world know that this is happening, that the LRA are STILL currently fighting and abducting, that the Ugandan People’s Defence Force are taking action to end the War.

98 Souls Saved, that is wonderful news to hear, such a great start to the day, after the week i have had of audits at work its a good news day. Lets just hope that the action continues. Through our awareness we are seeing action. STAND STRONG and USE YOUR VOICE.

Check out the News Report – CLICK HERE

Betty & Her Family

ALSO, Ive recently started sponsoring a Child Headed Household in Uganda. Betty is 16 and has a 3 month old baby of her own. Both parents are deceased and she is the caregiver for her 3 brother siblings (17) (12) & (11). To help me financially be able to support these children i have/am creating a range of items such as shirts, bags, hats, postcards and stickers to help me fund this. 100% of the profits are sent to support the children through a registered non profit “Joy For Children Uganda”. The funds are used to pay for food, kerosine (they live in a no electricity area), school fee’s, medical care and clothing. Their mother passed away in 2004 from AIDs and their father many years before their mother, however the children do not recall when. Since 2004 Betty has been the main provider for her brothers.

Your purchase will help me be able to help these 5 children have a chance at a better life. CLICK HERE to go to our store